Share Price:

APNASPENAspen Pharmacare Hldgs2193888 (0.40%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Stephen Saad scoops Entrepreneur of the Year Award

Johannesburg. Stephen Saad, Aspen Group Chief Executive, was announced as the winner of the Entrepreneur of the Year Award at the All Africa Business Leaders Awards (AABLA) gala banquet in Johannesburg. At the Awards, hosted in partnership with CNBC Africa, Stephen Saad said, “You work at something and you build something together with the team… Continue reading Stephen Saad scoops Entrepreneur of the Year Award

Aspen’s comparable revenue increases by 12% to R35.4 billion

Aspen’s comparable revenue increases by 12% to R35.4 billion Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company in the southern hemisphere, has announced positive results for the year ended 30 June 2016 notwithstanding economic pressures and currency weaknesses.   Stephen Saad, Aspen Group Chief Executive said, “The positive results… Continue reading Aspen’s comparable revenue increases by 12% to R35.4 billion

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.